Literature DB >> 10496177

5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation.

N A Khan1, J P Poisson.   

Abstract

The study was conducted on a human (Jurkat) T cell line, loaded with a Na+ fluorescent probe, SBFI/AM. Serotonin and an agonist of 5-HT3 receptor-channels, 2-methyl-5HT, evoked Na+ influx, whereas the agonists of other serotonergic receptor subtypes, i.e., 5-HT1A and 5-HT1B receptors, failed to induce Na+ influx in these cells. By using 3H-BRL43694, an agonist of 5-HT3 receptor-channels, we characterized 5-HT3 lymphocyte receptors which exhibited a density (Bmax) of 300 +/- 20 fmol/10(6) cells and a Kd of 30 nM in Jurkat T cells. The T-cell 5-HT3 receptor-channel is not regulated either by the protein kinase C or by the free intracellular calcium concentrations as the agents known to activate the PKC and to induce increases in intracellular free calcium concentrations failed to influence the free intracellular Na+ concentrations, [Na+]i, in these cells. Furthermore, an increase in [Na+]i, induced by 2-methyl-5HT, via 5-HT3 receptor-channels seems to stimulate T-cell activation by facilitating the progression of T cells from S to G2/M phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496177     DOI: 10.1016/s0165-5728(99)00101-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

Review 1.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

2.  Radiation-induced bystander effects in the Atlantic salmon (salmo salar L.) following mixed exposure to copper and aluminum combined with low-dose gamma radiation.

Authors:  Carmel Mothersill; Richard W Smith; Lene Sørlie Heier; Hans-Christian Teien; Ole Christian Lind; Ole Christian Land; Colin B Seymour; Deborah Oughton; Brit Salbu
Journal:  Radiat Environ Biophys       Date:  2013-12-19       Impact factor: 1.925

Review 3.  From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists.

Authors:  Gohar Fakhfouri; Kazem Mousavizadeh; Sharam Ejtemaei Mehr; Ahmad Reza Dehpour; Mohammad Reza Zirak; Jean-Eric Ghia; Reza Rahimian
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

Review 4.  [5-HT3 receptor antagonist als analgetics in rheumatic diseases].

Authors:  W Müller; B L Fiebich; T Stratz
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 5.  Hyperserotoninemia and altered immunity in autism.

Authors:  Nancy K Burgess; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2006-07

6.  CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.

Authors:  Hera Wu; DeVon Herr; Nancie J MacIver; Jeffrey C Rathmell; Valerie A Gerriets
Journal:  Int Immunopharmacol       Date:  2020-08-28       Impact factor: 4.932

7.  Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.

Authors:  Heather A O'Malley; Andrew B Shreiner; Gwo-Hsiao Chen; Gary B Huffnagle; Lori L Isom
Journal:  Mol Cell Neurosci       Date:  2008-11-01       Impact factor: 4.314

8.  Serotonin and its metabolites reduce oxidative stress in murine RAW264.7 macrophages and prevent inflammation.

Authors:  Ondřej Vašíček; Antonín Lojek; Milan Číž
Journal:  J Physiol Biochem       Date:  2020-01-03       Impact factor: 4.158

9.  Axonal protection achieved in a model of multiple sclerosis using lamotrigine.

Authors:  David A Bechtold; Sandra J Miller; Angela C Dawson; Yue Sun; Raju Kapoor; David Berry; Kenneth J Smith
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 10.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.